# CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients

> **NCT02262156** · NA · COMPLETED · sponsor: **El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez** · enrollment: 15 (actual)

## Conditions studied

- Depression
- Epilepsy, Temporal Lobe

## Interventions

- **OTHER:** Cognitive behavioral therapy
- **DRUG:** SSRI

## Key facts

- **NCT ID:** NCT02262156
- **Lead sponsor:** El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02262156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02262156, "CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT02262156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*